LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Ujjwal Ramtekkar Sells 16,000 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Ujjwal Ramtekkar sold 16,000 shares of the business’s stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the transaction, the insider now owns 113,435 shares of the company’s stock, valued at $673,803.90. This represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

LifeStance Health Group Price Performance

LFST traded up $0.04 during trading on Monday, hitting $5.88. The company’s stock had a trading volume of 1,692,560 shares, compared to its average volume of 1,601,939. The firm has a market capitalization of $2.29 billion, a price-to-earnings ratio of -22.62 and a beta of 1.22. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The business’s fifty day simple moving average is $6.24 and its 200 day simple moving average is $7.08. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Handelsbanken Fonder AB purchased a new stake in LifeStance Health Group in the 4th quarter worth $128,000. Janus Henderson Group PLC increased its stake in shares of LifeStance Health Group by 51.4% during the fourth quarter. Janus Henderson Group PLC now owns 59,500 shares of the company’s stock worth $439,000 after purchasing an additional 20,200 shares in the last quarter. Blue Trust Inc. increased its stake in shares of LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares in the last quarter. Northern Trust Corp raised its position in shares of LifeStance Health Group by 11.7% during the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company’s stock worth $11,731,000 after purchasing an additional 166,731 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in LifeStance Health Group by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company’s stock valued at $25,546,000 after buying an additional 13,293 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on LFST. KeyCorp began coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They issued an “overweight” rating and a $9.00 price objective on the stock. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price target on the stock. UBS Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $8.50 price target on the stock in a research report on Tuesday, May 27th. Finally, William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.